Group One Trading
INO icon

Group One Trading’s Inovio Pharmaceuticals INO Stock Holding History

Group One Trading’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$1.74K – 8140
2025
Q4 		$1.74K Sell
1,000
-8,200
-89% -$18.1K ﹤0.01% 7594
2025
Q3 		$21.5K Buy
9,200
+2,000
+28% +$3.83K ﹤0.01% 6644
2025
Q2 		$14.7K Buy
7,200
+4,900
+213% +$9.39K ﹤0.01% 6470
2025
Q1 		$3.75K Buy
2,300
+400
+21% +$803 ﹤0.01% 6766
2024
Q4 		$3.48K Sell
1,900
-31,600
-94% -$140K ﹤0.01% 6568
2024
Q3 		$194K Sell
33,500
-2,800
-8% -$23.1K ﹤0.01% 3646
2024
Q2 		$293K Sell
36,300
-4,200
-10% -$44.2K ﹤0.01% 3067
2024
Q1 		$562K Buy
40,500
+40,108
+10,232% +$346K ﹤0.01% 2615
2023
Q4 		$2.4K Hold
392
– – ﹤0.01% 6773
2023
Q3 		$1.83K Sell
392
-250
-39% -$1.38K ﹤0.01% 7071
2023
Q2 		$3.44K Sell
642
-533
-45% -$4.3K ﹤0.01% 6882
2023
Q1 		$11.6K Sell
1,175
-4,767
-80% -$81.3K ﹤0.01% 5854
2022
Q4 		$111K Sell
5,942
-4,450
-43% -$101K ﹤0.01% 4345
2022
Q3 		$215K Sell
10,392
-3,300
-24% -$84.5K ﹤0.01% 4068
2022
Q2 		$284K Sell
13,692
-12,350
-47% -$348K ﹤0.01% 3955
2022
Q1 		$1.12M Buy
26,042
+15,617
+150% +$703K ﹤0.01% 2964
2021
Q4 		$624K Sell
10,425
-3,417
-25% -$274K ﹤0.01% 3868
2021
Q3 		$1.19M Buy
13,842
+2,134
+18% +$214K ﹤0.01% 3219
2021
Q2 		$1.3M Sell
11,708
-7,425
-39% -$713K ﹤0.01% 3105
2021
Q1 		$2.13M Sell
19,133
-1,409
-7% -$185K ﹤0.01% 2395
2020
Q4 		$2.18M Sell
20,542
-9,341
-31% -$1.24M ﹤0.01% 1973
2020
Q3 		$4.16M Buy
29,883
+8,591
+40% +$1.79M 0.01% 1036
2020
Q2 		$6.89M Buy
21,292
+13,442
+171% +$2.16M 0.03% 608
2020
Q1 		$701K Buy
7,850
+5,242
+201% +$323K 0.01% 1805
2019
Q4 		$103K Buy
2,608
+675
+35% +$20.3K ﹤0.01% 3618
2019
Q3 		$48K Sell
1,933
-1,275
-40% -$38.8K ﹤0.01% 3989
2019
Q2 		$113K Buy
3,208
+558
+21% +$22.2K ﹤0.01% 3258
2019
Q1 		$119K Buy
2,650
+1,358
+105% +$68.4K ﹤0.01% 3060
2018
Q4 		$62K Sell
1,292
-850
-40% -$51.6K ﹤0.01% 3439
2018
Q3 		$143K Sell
2,142
-900
-30% -$50.1K ﹤0.01% 3256
2018
Q2 		$143K Buy
3,042
+2,517
+479% +$139K ﹤0.01% 3321
2018
Q1 		$30K Sell
525
-67
-11% -$3.63K ﹤0.01% 3912
2017
Q4 		$29K Sell
592
-3,583
-86% -$222K ﹤0.01% 4005
2017
Q3 		$318K Buy
4,175
+3,392
+433% +$252K ﹤0.01% 2416
2017
Q2 		$74K Buy
783
+450
+135% +$38.5K ﹤0.01% 3294
2017
Q1 		$26K Sell
333
-5,850
-95% -$466K ﹤0.01% 3765
2016
Q4 		$515K Sell
6,183
-3,909
-39% -$353K 0.01% 1754
2016
Q3 		$1.13M Buy
10,092
+809
+9% +$89.4K 0.01% 1193
2016
Q2 		$1.03M Buy
9,283
+1,208
+15% +$147K 0.01% 1237
2016
Q1 		$844K Sell
8,075
-10,408
-56% -$804K 0.01% 1305
2015
Q4 		$1.49M Buy
18,483
+1,408
+8% +$112K 0.02% 1047
2015
Q3 		$1.18M Buy
17,075
+1,983
+13% +$173K 0.02% 1118
2015
Q2 		$1.48M Buy
15,092
+12,217
+425% +$1.31M 0.02% 938
2015
Q1 		$282K Sell
2,875
-6,308
-69% -$611K ﹤0.01% 2098
2014
Q4 		$1.01M Sell
9,183
-21,084
-70% -$2.58M 0.02% 1070
2014
Q3 		$3.58M Buy
30,267
+14,317
+90% +$1.78M 0.06% 415
2014
Q2 		$2.07M Buy
15,950
+12,977
+436% +$1.53M 0.03% 671
2014
Q1 		$475K Buy
+2,973
New +$427K 0.01% 1679

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's INO Position: Q2 2025 in Review

Group One Trading sold out of Inovio Pharmaceuticals (INO) in Q2 2025, closing a stake of 2,924 shares — an estimated $5.6K sold.

Group One Trading first reported a position in INO in Q1 2014 and held it in 30 quarters. The position peaked at $1.04M in Q2 2015. 103 funds tracked by Wall St. Rank hold INO as of Q2 2025.

  • Group One Trading reported no remaining Inovio Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 2,924 Inovio Pharmaceuticals shares in Q2 2025, an estimated $5.6K.
  • Group One Trading first reported a position in Inovio Pharmaceuticals in Q1 2014 and held it in 30 quarters.
  • Group One Trading's Inovio Pharmaceuticals position peaked at $1.04M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.